Companies: 10,795·Total market cap: $144.5T
Adagene Inc.

Adagene Inc.

ADAGNASDAQHealthcare● Active
$3.34
+$0.08(+2.45%)
Market Cap$125746317
P/E Ratio—
52W High$4.75
52W Low$1.3
SEC Filings
Foreign Private Issuer · Files 20-F / 6-K

Adagene Inc. (ADAG) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001818838 · ADAG · NASDAQ · as of Jun 9, 2026

Filing snapshot

172
Total Filings
SCHEDULE 13D/A
Latest Form
2026-06-08
Most Recent
2021
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001818838 · Updated hourly · Not investment advice

Latest Annual Report

20-F · Annual Report (Foreign Issuer)FY
Filed Date
2026-04-01
Fiscal Year End
Apr 1, 2026
Accession No.
0001104659-26-038612
Primary Document
adag-20251231x20f.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001818838 · Accession 0001104659-26-038612

Latest Key Filings

6-KQuarterly Report
FORM 6-K
2026-04-17
View 6-K on SEC
8-KCurrent Report

No recent filings

Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
SCHEDULE 13D/ASCHEDULE 13D/A
SCHEDULE 13D/A
2026-06-08
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-05-15
View
SCHEDULE 13GSCHEDULE 13G
SCHEDULE 13G
2026-05-07
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-04-17
View
424B5424B5
424B5
2026-04-02
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-04-02
View
424B5424B5
424B5
2026-04-02
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-04-02
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-04-01
View
20-FAnnual Report (Foreign Issuer)
20-F
2026-04-01
View
SCHEDULE 13GSCHEDULE 13G
SCHEDULE 13G
2026-03-18
View
3Initial Statement of Beneficial Ownership
OWNERSHIP DOCUMENT
2026-03-18
View
3Initial Statement of Beneficial Ownership
OWNERSHIP DOCUMENT
2026-03-18
View
3Initial Statement of Beneficial Ownership
OWNERSHIP DOCUMENT
2026-03-18
View
3Initial Statement of Beneficial Ownership
OWNERSHIP DOCUMENT
2026-03-18
View
Showing 1–15 of 170 filingsForm 4 / 144 hidden· 172 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001818838  |  Exchange: NASDAQ · Healthcare

Adagene Inc. (NASDAQ: ADAG) has submitted 172 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2021. As a Healthcare sector company with CIK 0001818838, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Adagene Inc.'s most comprehensive regulatory disclosure. The most recent Adagene Inc. 10-K was filed on 2026-04-01 for fiscal year ending 2026. Historical ADAG 10-K annual reports are available from 2020 through 2026.

Investors researching Adagene Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-09
Related Companies SEC Filings — Healthcare
FBIO SEC Filings →OSTX SEC Filings →NRXP SEC Filings →XBIT SEC Filings →GANX SEC Filings →ACET SEC Filings →TCRX SEC Filings →NTRB SEC Filings →
→ ADAG Financials→ ADAG Earnings→ ADAG Insider Trades

Frequently Asked Questions

ADAG SEC Filings · 8 questions

Adagene Inc. (ADAG) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 172 filings and access original documents at no cost. Adagene Inc.'s CIK is 0001818838.

ADAG SEC filingsAdagene Inc. SEC documentsfind ADAG 10-K